

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
I-Polatuzumab vedotin iyikhambi lomdlavuza eliqondiswe ngqo elihlanganisa i-antibody nomuthi we-chemotherapy ukwelapha izinhlobo ezithile zomdlavuza wegazi. Lokhu kwelashwa okusha kusebenza njengemishini eqondisiwe, iletha i-chemotherapy ngqo emangqamuzaneni omdlavuza ngenkathi isindisa izicubu ezinempilo kakhulu kune-chemotherapy yendabuko.
Ungase ufunde lokhu ngoba wena noma othile omkhathalelayo unikezwe lo muthi. Kuyinto ejwayelekile ngokuphelele ukuba nemibuzo mayelana nanoma yikuphi ukwelashwa komdlavuza, futhi ukuqonda okulindelekile kungakusiza uzizwe ulungile futhi unethemba ohambweni lwakho lokunakekelwa.
I-Polatuzumab vedotin iyi-antibody-drug conjugate, okusho ukuthi imithi emibili esebenza ndawonye njengenye. Ingxenye ye-antibody isebenza njengedivayisi yokuzula efuna amaseli athile omdlavuza, ngenkathi ingxenye ye-chemotherapy ibhubhisa lawo maseli uma i-antibody iwabona.
Le ndlela eqondiswe ngqo imelela intuthuko enkulu ekwelashweni komdlavuza. Esikhundleni sokuthinta wonke amaseli ahlukanisa ngokushesha njenge-chemotherapy yendabuko, i-polatuzumab vedotin igxila ngqo emangqamuzaneni omdlavuza aneprotein ebizwa nge-CD79b ebusweni bawo. Lokhu kunemba kusiza ukunciphisa eminye yemiphumela emibi ongase uyithole nge-chemotherapy yendabuko.
Lo muthi ungowesigaba semithi ebizwa ngokuthi ama-monoclonal antibodies. Cabanga ngayo njengokhiye oklanywe ngokukhethekile ovuleka kuphela emalini etholakala kumangqamuzana athile omdlavuza, okwenza ukwelashwa kube nokukhetha okwengeziwe futhi kuvame ukubekezeleleka.
I-Polatuzumab vedotin iphatha i-diffuse large B-cell lymphoma (DLBCL), uhlobo lomdlavuza wegazi oluthinta amasosha akho omzimba. Udokotela wakho ngokuvamile uzoncoma lo muthi lapho okunye ukwelashwa kungasebenzi njengoba bekulindelwe, noma lapho umdlavuza ubuyela ngemva kokwelashwa kwangaphambilini.
Lo muthi uvunyelwe ngokuqondile kubantu abadala abane-DLBCL ebuyele emuva noma e-refractory. "Ukubuyela emuva" kusho ukuthi umdlavuza ubuyile ngemuva kokwelashwa, kanti "i-refractory" kusho ukuthi awuzange usabele kahle emithini yangaphambilini. Udokotela wakho we-oncologist ngokuvamile uzohlanganisa i-polatuzumab vedotin neminye imithi yomdlavuza ukuze akhe uhlelo lokwelashwa olubanzi.
Ukwelashwa ngokuvamile kugcinelwe abantu asebevele bazamile okungenani enye imithi. Ithimba lakho lezokwelapha lizohlola ngokucophelela isimo sakho esithile, okuhlanganisa impilo yakho yonke, izici zomdlavuza wakho, kanye nomlando wakho wokwelashwa ukuze linqume ukuthi lo muthi ukufanele yini.
I-Polatuzumab vedotin isebenza ngokuletha i-chemotherapy ngokuqondile emangqamuzaneni omdlavuza ngenqubo yezinyathelo ezimbili. Okokuqala, ingxenye ye-antibody ihamba ngegazi lakho bese inamathisela kuma-protein e-CD79b atholakala ebusweni bamaseli athile e-lymphoma.
Lapho i-antibody isinamathele eseleni lomdlavuza, ikhipha umuthi we-chemotherapy ngaphakathi kweseli. Lolu hlelo lokulethwa oluqondiwe lisho ukuthi i-chemotherapy ingasebenza lapho idingeka kakhulu ngenkathi kungenzeka ukuthi ibangela imiphumela emibi embalwa emangqamuzaneni anempilo emzimbeni wakho wonke.
Lokhu kuthathwa njengokwelashwa komdlavuza okuphakathi nendawo. Ngenkathi iqondiwe kakhulu kune-chemotherapy yendabuko, iseyimithi engathi sína edinga ukuqashwa ngokucophelela. Ithimba lakho lezempilo lizokubuka eduze ngesikhathi sokwelashwa ukuze liqinisekise ukuthi liyasebenza ngempumelelo nokulawula noma yimiphi imiphumela emibi engase ivele.
I-Polatuzumab vedotin inikezwa njenge-intravenous (IV) infusion esikhungweni sokwelashwa komdlavuza noma esibhedlela. Ngeke uthathe lo muthi ekhaya - idinga ukuphathwa ngobuchwepheshe ngabahlinzeki bezempilo abaqeqeshiwe abangochwepheshe ekunakekelweni komdlavuza.
Ukunikezwa ngomjovo kuvame ukuthatha imizuzu engaba ngu-90 ngomthamo wakho wokuqala, futhi imithamo elandelayo ivame ukuthatha imizuzu engaba ngu-30. Uzothola imithi ngeshubhu elincane elifakwe emthanjeni, ngokuvamile engalweni yakho. Umhlengikazi wakho uzokuqapha eduze ngesikhathi sonke senqubo yokunikezwa ngomjovo.
Ngaphambi kokwelashwa ngakunye, ungase uthole imithi yangaphambi kokwelashwa ukusiza ukuvimbela ukusabela komzimba noma isicanucanu. Lokhu kungabandakanya ama-antihistamines, ama-steroids, noma imithi elwa nesicanucanu. Ithimba lakho lezempilo lizochaza okulindelekile futhi likusize uzizwe ukhululekile ngangokunokwenzeka ngesikhathi senqubo.
Akudingeki ukuthi usebenzise le mithi nokudla ngoba iya ngqo egazini lakho. Kodwa-ke, ukudla ukudla okulula ngaphambi kokwelashwa kungakusiza ukuthi uzizwe uzinzile futhi kunganciphisa isicanucanu. Hlala unamanzi ngaphambi nangemva kokunikezwa ngomjovo ngaphandle uma udokotela wakho ekweluleka ngenye indlela.
Abantu abaningi bathola i-polatuzumab vedotin imijikelezo efinyelela kweyisithupha, umjikelezo ngamunye uthatha izinsuku ezingama-21. Lokhu kusho ukuthi ngokuvamile uzothola imithi kanye njalo emavikini amathathu cishe izinyanga ezine kuya kwezinhlanu, nakuba isimiso sakho esiqondile singahluka ngokuya ngohlelo lwakho oluqondile lokwelashwa.
Udokotela wakho we-oncologist uzoqoka isikhathi esiqondile esisekelwe ekutheni umdlavuza uphendula kahle kangakanani ekwelashweni nokuthi ukumelana kahle kangakanani nemithi. Abanye abantu bangase bathole imijikelezo embalwa uma umdlavuza uphendula ngokushesha, kanti abanye bangase badinge ukulungiswa esimisweni sabo uma imiphumela emibi idinga isikhathi esiningi sokululama.
Kuyo yonke imithi yakho, ithimba lakho lezokwelapha lizohlola njalo izibalo zegazi lakho, liqaphe izitho zakho, futhi lihlole ukuthi umdlavuza uphendula kanjani. Lezi zivivinyo zisiza ukuqinisekisa ukuthi imithi isebenza ngempumelelo nokuthi iphephile ukuthi uqhubeke nokwelashwa.
Njengazo zonke izindlela zokwelapha umdlavuza, i-polatuzumab vedotin ingabangela imiphumela emibi, nakuba abantu abaningi beyibekezelela kahle. Ukuqonda okulindelekile kungakusiza ukuthi uqaphele izimpawu kusenesikhathi futhi uthole ukwesekwa okudingayo.
Nawa amanye emiphumela emibi evame kakhulu ongase uyithole ngesikhathi sokwelashwa:
Le miphumela emibi ingalawulwa ngokunakekelwa okufanele kanye nemithi. Ithimba lakho lezempilo lizokunikeza amasu aqondile okusiza ukunciphisa ukungakhululeki futhi ugcine izinga lempilo yakho ngesikhathi sokwelashwa.
Nakuba kungavamile, abanye abantu bangase babe nemiphumela emibi engathi sína edinga ukunakekelwa kwezempilo ngokushesha:
Ithimba lakho lezokwelapha lizokuqapha eduze ukuze libone lezi zinkinga ezingavamile kodwa ezingathi sína. Bazokufundisa izimpawu zokuxwayisa okufanele uzibheke futhi banikeze imiyalelo ecacile yokuthi ungaxhumana nabo nini ngokushesha.
I-Polatuzumab vedotin ayifanele wonke umuntu, futhi i-oncologist yakho izohlola ngokucophelela ukuthi iphephile yini kuwe. Abantu abanezimo ezithile zempilo noma izimo bangase badinge ukwelashwa okuhlukile.
Akufanele uthole lo muthi uma wazi ukuthi unokungezwani okukhulu ne-polatuzumab vedotin noma yiziphi izithako zayo. Udokotela wakho uzophinda aqaphele uma unezifo eziqhubekayo, ezingathi sína ngoba umuthi ungase ucindezele amasosha akho omzimba ngokuqhubekayo.
Abantu abanezinkinga ezinzima zesibindi bangase badinge ukulungiswa kwemithamo noma ezinye izindlela zokwelapha, njengoba umuthi usetshenzwa esibindini. Ithimba lakho lezempilo lizohlola ukusebenza kwesibindi sakho ngaphambi kokuqala ukwelashwa futhi liqaphe ngaso sonke isikhathi sokunakekelwa kwakho.
Uma ukhulelwe noma uncelisa, lo muthi ungalimaza ingane yakho. Udokotela wakho uzoxoxa ngezindlela zokuvimbela ukukhulelwa eziphephile uma uneminyaka yokuzala, futhi uzodinga ukusebenzisa izindlela zokulawula ukuzala eziphumelelayo ngesikhathi sokwelashwa kanye nasezinyangeni eziningana ngemuva kwalokho.
I-Polatuzumab vedotin ithengiswa ngaphansi kwegama lomkhiqizo elithi Polivy. Leli yilo kuphela igama lomkhiqizo elitholakala njengamanje ngalo muthi, njengoba kuyindlela yokwelapha ekhethekile ekhiqizwa yinkampani eyodwa yezemithi.
Ungase ubone igama eliphelele libhalwe njenge- "polatuzumab vedotin-piiq" emarekhodini akho ezokwelapha noma olwazini lwemithi kadokotela. Ingxenye ethi "piiq" iyisijobelelo esisiza ukuhlukanisa le fomula ethile kweminye imithi efanayo engase ithuthukiswe esikhathini esizayo.
Uma nixoxa ngokwelashwa kwakho nabahlinzeki bezempilo noma izinkampani zomshuwalense, ungalibiza nganoma yiliphi igama - Polivy noma polatuzumab vedotin. Zombili zibhekisela emuthini ofanayo.
Uma i-polatuzumab vedotin ingakulungele, kunezinketho eziningana zokwelapha ezinye ze-DLBCL eziphindelelayo noma ezingamelani nokwelashwa. Udokotela wakho we-oncologist uzokusiza ukuthi uhlole ezinye izindlela ngokusekelwe esimweni sakho esithile kanye nomlando wezokwelapha.
Ukwelashwa ngamaseli e-CAR-T kungenye inketho yokwelapha ethuthukisiwe lapho amaseli akho omzimba aguqulwa khona ukuze alwe nomdlavuza ngempumelelo. Lokhu kwelashwa kudinga inqubo ekhethekile futhi ngokuvamile kwenziwa ezikhungweni ezinkulu zomdlavuza.
Izinhlanganisela zendabuko ze-chemotherapy ezifana ne-R-ICE noma i-R-DHAP zihlala ziyizindlela ezibalulekile, ikakhulukazi kubantu abangase babe ngabazongenela ukufakelwa kwamaselula esiqu. Lezi zindlela zokwelapha zisebenzisa izinhlanganisela ezahlukene zemithi ezingase zifaneleke kangcono ezimweni zakho ezithile.
Izivivinyo zemitholampilo zingase futhi zinikeze ukufinyelela ezindleleni zokwelapha ezintsha zokuhlola. Ithimba lakho lokunakekelwa kwezempilo lingakusiza ukuthi uqonde ukuthi ngabe yiziphi izifundo eziqhubekayo ezingase zifanele isimo sakho.
I-Polatuzumab vedotin ne-rituximab zisebenza ngendlela ehlukile futhi zivame ukusetshenziswa ndawonye kunokuthi zibe ezinye. I-Rituximab iyisithako esisodwa esiqondiswe kuma-CD20 amaprotheni kuma-B-cell lymphomas, kuyilapho i-polatuzumab vedotin iqondisa ama-CD79b amaprotheni.
Kunokuthi zibe ngcono noma zibe zimbi, le mithi iyazwanana. Izinhlelo eziningi zokwelapha zihlanganisa i-polatuzumab vedotin ne-rituximab kanye ne-chemotherapy ukuhlasela umdlavuza emazingeni amaningi. Le ndlela yokuhlanganisa ivame ukunikeza imiphumela engcono kunokusebenzisa noma iyiphi imithi yodwa.
Udokotela wakho we-oncologist uzoklama uhlelo lokwelapha olungase lubandakanye le mithi yomibili, kuye ngohlobo lwakho oluthile lwe-lymphoma nempilo yakho yonke. Umgomo uwukudala inhlanganisela yokwelapha esebenza kahle kakhulu ngenkathi kulawulwa imiphumela emibi ngendlela efanele.
Abantu abanezimo zenhliziyo bangavame ukuthola i-polatuzumab vedotin, kodwa udokotela wakho wenhliziyo kanye ne-oncologist kuzodingeka basebenze ndawonye ukuze bakuqaphele ngokucophelela. Umuthi ngokwawo ngokuvamile awubangeli izinkinga zenhliziyo eziqondile, kodwa ukwelashwa komdlavuza ngezinye izikhathi kungathinta ukusebenza kwenhliziyo.
Ithimba lakho lezokwelapha cishe lizokwenza izivivinyo zomsebenzi wenhliziyo ngaphambi kokuqala ukwelashwa futhi lingase liqaphe inhliziyo yakho ngesikhathi sokwelashwa. Uma unesifo senhliziyo esikhulu, bangase balungise isimiso sakho sokwelashwa noma banikeze ukunakekelwa okwengeziwe kokusekela ukuvikela impilo yenhliziyo yakho.
Njengoba i-polatuzumab vedotin inikezwa ochwepheshe bezempilo endaweni yezokwelapha elawulwayo, ukweqisa ngengozi akuvamile kakhulu. Umuthi ubhalwa ngokucophelela ngokuya ngesisindo somzimba wakho futhi unikezwa ngabanakekeli abaqeqeshiwe abahlola kabili umthamo.
Uma ukhathazekile ngomthamo wakho noma uhlangabezana nezimpawu ezingavamile ngemuva kokwelashwa, xhumana nethimba lakho lezempilo ngokushesha. Bangahlola isimo sakho futhi banikeze ukunakekelwa okufanele uma kudingeka. Isikhungo sokwelashwa sizoba nezimiso zokubhekana nanoma yikuphi ukukhathazeka ngomthamo.
Uma uphuthelwa i-aphoyintimenti ehleliwe ye-polatuzumab vedotin, xhumana nesikhungo sakho sokwelashwa umdlavuza ngokushesha ngangokunokwenzeka ukuze uhlele kabusha. Bazosebenza nawe ukuze ubuyele emgqeni nohlelo lwakho lokwelashwa ngaphandle kokuyekethisa ukusebenza kwalo.
Ithimba lakho lezempilo lingase lidingeke ukuthi lilungise isimiso sakho kancane, kodwa ukuphuthelwa umthamo owodwa ngokuvamile akudingi ukuqala phansi. Bazohlola ukuthi ukubambezeleka kungase kulithinte kanjani ukwelashwa kwakho futhi benze noma yiziphi izinguquko ezidingekayo ukuze baqinisekise ukuthi uthola inzuzo ephelele yokwelashwa kwakho.
Ngokuvamile uzoqeda inkambo yakho ehleliwe ye-polatuzumab vedotin ngemuva kwemijikelezo eyisithupha, kodwa udokotela wakho we-oncologist uzoqeda isinqumo ngokusekelwe ekutheni ukwelashwa kusebenza kahle kangakanani nokuthi ukukubekezelela kanjani. Abanye abantu bangase bayeke ngaphambi kwesikhathi uma bethola impendulo enhle kakhulu noma uma imiphumela emibi iba nzima kakhulu ukuyilawula.
Udktela wakho uzosebenzisa izithombe, ukuhlolwa kwegazi, nokuhlolwa komzimba ukuze anqume ukuthi kufanele nini ukuyeka ukwelashwa. Bazophinde baxoxe ngokuthi yini elandelayo ohlelweni lwakho lokunakekelwa, kungakhathaliseki ukuthi ukubheka, ukwelashwa kokugcina, noma ezinye izindlela zokwelapha.
Abantu abaningi bangaqhubeka nokusebenza ngenkathi bethola i-polatuzumab vedotin, nakuba kungase kudingeke ukuthi wenze izinguquko ezithile esimisweni sakho. Ukwelashwa kunikezwa kanye njalo emavikini amathathu, ngakho-ke uzodinga isikhathi sokuphumula seziqeshana zokufaka, futhi ungase ufune ukuhlela izinsuku ezilula ngokushesha ngemva kokwelashwa.
Ukukhathala kuyisiphumela esivamile, ngakho-ke ungase uthole ukuthi udinga ukuphumula okwengeziwe kunokujwayelekile. Xoxa nomqashi wakho mayelana nezinhlelo eziguquguqukayo uma kungenzeka, futhi ulalele umzimba wakho mayelana nokuthi yini ezizwa ilawuleka. Ithimba lakho lokunakekelwa kwezempilo linganikeza isiqondiso mayelana nemikhawulo yokusebenza uma kudingeka.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.